8-methyl-4-(2,4,6-trimethylbenzoyl)-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

Methyl 2-methyl-2-(4-nitro-1H-imidazol-1-yl)propanoate, 95%, 100g

6-Ethoxy-4-methylpyridin-3-amine hydrochloride, 5g

METHYL 4-BROMO-3-METHYLTHIENO[2,3-C]PYRIDINE-2-CARBOXYLATE, 95.0%, 500mg

4-Bromo-2-(trifluoromethyl)benzenesulfonylchloride, 97.0%, 100g

1-[2-(1-Pyrrolidinyl)ethyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 5g

TERT-BUTYL (4R)-4-(BROMOMETHYL)-2,2-DIMETHYL-1,3-OXAZOLIDINE-3-CARBOXYLATE, 95.0%, 1g

Plan PLi 20x/0.40 IOS infinity corrected objective

Putrescine, min. 99%, for biochemistry, 500 g, glass packaging

3-Cyano-6-methyl-2-pyridone, 97.0%, 10g

(3-(4-Methylpiperazin-1-yl)phenyl)methanol, 95.0%, 5g

4-Hydroxy-1-methyl-1,2-dihydropyridin-2-one, 98+%, 100mg

3,9-Bis(octadecyloxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane, 98% Carbon 64.8-69.5 %, 500g